Biology and therapeutic targeting of molecular mechanisms in MPNs

por How, Joan, Garcia, Jacqueline S., Mullally, Ann
Publicado 2023

Oops!...Glutamate Did it Again

por Garcia, Jacqueline P., Dulla, Chris G.
Publicado 2021

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes

por Garcia, Jacqueline S, Jain, Nitin, Godley, Lucy A
Publicado 2010

Effects of functional physical activity on the maintenance of motor function in Alzheimer’s disease

por Fajersztajn, Laís, Cordeiro, Renata Cereda, Andreoni, Solange, Garcia, Jacqueline Takayanagi
Publicado 2008

Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells

por Huang, Min, Zhu, Li, Garcia, Jacqueline S., Li, Michael X., Gentles, Andrew J., Mitchell, Beverly S.
Publicado 2018

Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials

por Hantel, Andrew, Luskin, Marlise R., Garcia, Jacqueline S., Stock, Wendy, DeAngelo, Daniel J., Abel, Gregory A.
Publicado 2021

Mathematical modeling of pathogenicity of Cryptococcus neoformans

por Garcia, Jacqueline, Shea, John, Alvarez-Vasquez, Fernando, Qureshi, Asfia, Luberto, Chiara, Voit, Eberhard O, Del Poeta, Maurizio
Publicado 2008

Morphogenesis signaling components influence cell cycle regulation by cyclin dependent kinase

por Tobe, Brian TD, Kitazono, Ana A, Garcia, Jacqueline S, Gerber, Renee A, Bevis, Brooke J, Choy, John S, Chasman, Daniel, Kron, Stephen J
Publicado 2009

Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells

por Huang, Min, Garcia, Jacqueline S., Thomas, Daniel, Zhu, Li, Nguyen, Le Xuan Truong, Chan, Steven M., Majeti, Ravindra, Medeiros, Bruno C., Mitchell, Beverly S.
Publicado 2016

Defining disease modification in myelofibrosis in the era of targeted therapy

por Pemmaraju, Naveen, Verstovsek, Srdan, Mesa, Ruben, Gupta, Vikas, Garcia, Jacqueline S., Scandura, Joseph M., Oh, Stephen T., Passamonti, Francesco, Döhner, Konstanze, Mead, Adam J.
Publicado 2022

Neuronal activity drives pathway-specific depolarization of peripheral astrocyte processes

por Armbruster, Moritz, Naskar, Saptarnab, Garcia, Jacqueline P, Sommer, Mary, Kim, Elliot, Adam, Yoav, Haydon, Philip G, Boyden, Edward S, Cohen, Adam E, Dulla, Chris G
Publicado 2022

Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 Pandemic

por Raman, Hari S., Flamand, Yael, Luskin, Marlise R., DeAngelo, Daniel J., Stone, Richard M., Garcia, Jacqueline S., Wadleigh, Martha, Charles, Anne, Copson, Kevin, Lindsley, R. Coleman, Vedula, Rahul S., Winer, Eric S.
Publicado 2021

BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia

por Olesinski, Elyse A., Bhatia, Karanpreet S., Mahesh, Aarthi N., Rosli, Shazwina, Mohamed, Jameelah S., Jen, Wei Y., Jain, Nitin, Garcia, Jacqueline S., Wong, Gee C., Ooi, Melissa, Letai, Anthony, Konopleva, Marina, Bhatt, Shruti
Publicado 2023

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

por Shimony, Shai, Fell, Geoffrey, Chen, Evan C., Tsai, Harrison K., Wadleigh, Martha, Winer, Eric S., Garcia, Jacqueline S., Luskin, Marlise R., Stahl, Maximilian, Neuberg, Donna S., DeAngelo, Daniel J., Lindsley, R. Coleman, Stone, Richard M.
Publicado 2023

Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia

por Konopleva, Marina, Thirman, Michael J., Pratz, Keith W., Garcia, Jacqueline S., Recher, Christian, Pullarkat, Vinod, Kantarjian, Hagop M., DiNardo, Courtney D., Dail, Monique, Duan, Yinghui, Chyla, Brenda, Potluri, Jalaja, Miller, Catherine L., Wei, Andrew H.
Publicado 2022

A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes

por Zeidan, Amer M., Borate, Uma, Pollyea, Daniel A., Brunner, Andrew M., Roncolato, Fernando, Garcia, Jacqueline S., Filshie, Robin, Odenike, Olatoyosi, Watson, Anne Marie, Krishnadasan, Ravitharan, Bajel, Ashish, Naqvi, Kiran, Zha, Jiuhong, Cheng, Wei‐Han, Zhou, Ying, Hoffman, David, Harb, Jason G., Potluri, Jalaja, Garcia‐Manero, Guillermo
Publicado 2022

P579: SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF AZD5991 IN RELAPSED/ REFRACTORY HEMATOLOGIC MALIGNANCIES: A PHASE 1 FIRST-IN-HUMAN STUDY

por Desai, Pinkal, Lonial, Sagar, Cashen, Amanda, Kamdar, Manali, Blachly, James S., Flinn, Ian W., O’brien, Susan, Garcia, Jacqueline, Korde, Neha, Moslehi, Javid, Wey, Margaret, Cheung, Patricia, Sharma, Shringi, Olabode, Damilola, Chen, Hong, Ali Syed, Firasath, Liu, Mary, Saeh, Jamal, Tibes, Raoul, Andrade, Marcio, Kadia, Tapan
Publicado 2023

Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine

por Pratz, Keith W., Jonas, Brian A., Pullarkat, Vinod, Recher, Christian, Schuh, Andre C., Thirman, Michael J., Garcia, Jacqueline S., DiNardo, Courtney D., Vorobyev, Vladimir, Fracchiolla, Nicola S., Yeh, Su-Peng, Jang, Jun Ho, Ozcan, Muhit, Yamamoto, Kazuhito, Illes, Arpad, Zhou, Ying, Dail, Monique, Chyla, Brenda, Potluri, Jalaja, Döhner, Hartmut
Publicado 2022

Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy

por Harrison, Claire N., Garcia, Jacqueline S., Somervaille, Tim C.P., Foran, James M., Verstovsek, Srdan, Jamieson, Catriona, Mesa, Ruben, Ritchie, Ellen K., Tantravahi, Srinivas K., Vachhani, Pankit, O'Connell, Casey L., Komrokji, Rami S., Harb, Jason, Hutti, Jessica E., Holes, Leanne, Masud, Abdullah A., Nuthalapati, Silpa, Potluri, Jalaja, Pemmaraju, Naveen
Publicado 2022